• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Small EDRK-rich factor 1 (SERF1A)

ACP21145

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21145 Target NameSERF1A
Target SynonymsSERF1A; FAM2A; SERF1; SMAM1;; SERF1B; FAM2B; SERF1; SMAM1; Small EDRK-rich factor 1; Protein 4F5; h4F5; SMA modifier 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-110
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO75920
Background Information
  • Uniprot Id

    O75920

  • Target Species

    Human

  • Target Name

    SERF1A

  • Target Full Name

    Small EDRK-rich factor 1

  • Target Function

    Positive regulator of amyloid protein aggregation and proteotoxicity. Induces conformational changes in amyloid proteins, such as APP, HTT, and SNCA, driving them into compact formations preceding the formation of aggregates.

  • Target Subcellular Location

    Cytoplasm, cytosol. Nucleus.

  • Target Protein Families

    SERF family

  • Target Tissue Specificity

    Isoform Long is predominantly expressed in heart, brain and skeletal muscle. Isoform Short and Isoform Long are expressed throughout the central nervous system, including spinal cord.

  • Target Synonyms

    SERF1A; FAM2A; SERF1; SMAM1;; SERF1B; FAM2B; SERF1; SMAM1; Small EDRK-rich factor 1; Protein 4F5; h4F5; SMA modifier 1

Inquire Recombinant Human Small EDRK-rich factor 1 (SERF1A) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification